Mark R. Witmer - Concepedia

Author

Mark R. Witmer

Bristol-Myers Squibb (United States)ORCID

Also Known As

M R Witmer, M. R. Witmer, M.R. Witmer, Marissa Witmer, Mark R. Witmer, Mark R Witmer, Mark R. Witmer, Mark Witmer, Witmer, Mark

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)Princeton University Biocon (India)

About

Mark R. Witmer is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	14	14	502
2	Natural Sciences	13	13	461
3	Medicine	12	12	486
4	Engineering	1	1	97
5	Health Sciences	1	1	29

Mark R. Witmer

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation Steve Poirier, Gaétan Mayer, Viviane Poupon, Journal of Biological Chemistry	2009	265
Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering Tracy Mitchell, Ginger Chao, Doree Sitkoff, Journal of Pharmacology and Experimental Therapeutics	2014	128
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain John S. Tokarski, Adriana Zupa-Fernandez, Jeffrey Tredup, Journal of Biological Chemistry	2015	112
2-Aryl-2,2-difluoroacetamide FKBP12 Ligands: Synthesis and X-ray Structural Studies Gene M. Dubowchik, Vivekananda M. Vrudhula, Bireshwar Dasgupta, Organic Letters Chemical BiologyX-ray Structural StudiesHalogenationPharmaceutical ChemistryBiochemistry	2001	103
Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase Robert G. Gentles, Min Ding, John A. Bender, Journal of Medicinal Chemistry	2014	98
A global benchmark study using affinity-based biosensors Rebecca L. Rich, Giuseppe A. Papalia, Peter J. Flynn, Analytical Biochemistry EngineeringGlobal Benchmark StudyBioanalysisSensor DesignBiomedical Engineering	2008	97
Imidazoquinoxaline Src-Family Kinase p56<sup>Lck</sup> Inhibitors: SAR, QSAR, and the Discovery of (<i>S</i>)-<i>N</i>-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity Ping Chen, Arthur M. Doweyko, Derek Norris, Journal of Medicinal Chemistry ImmunologyPharmacotherapyHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	2004	55
Decrypting the Biochemical Function of an Essential Gene from Streptococcus pneumoniae Using ThermoFluor® Technology Theodore E. Carver, Brian Bordeau, Maxwell D. Cummings, Journal of Biological Chemistry	2005	55
Antithrombin III-beta associates more readily than antithrombin III-alpha with uninjured and de-endothelialized aortic wall in vitro and in vivo. Mark R. Witmer, M.W.C. Hatton Arteriosclerosis and Thrombosis A Journal of Vascular Biology Vascular DiseaseImmunologyRabbit Antithrombin IiiAtiii-beta BoundInflammation	1991	53
Kinetic Studies on β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE) Larisa Toulokhonova, William J. Metzler, Mark R. Witmer, Journal of Biological Chemistry	2003	49

Page 1